diversification.com

LLY.TO

Companies
NEO
Eli Lilly and Company
Healthcare
OverviewNewsRisk & CorrelationForecasts
Price Chart
Overview

About LLY.TO

A leading pharmaceutical firm known for its innovative treatments in areas such as neuroscience, diabetes, oncology, and immunology.

Market Cap
$831.7B
Volume
1.5M
Avg. Volume
1.3M
P/E Ratio
Dividend Yield
0.40%
Employees
41.9K

Company Information

Exchange
NEO
Sector
Healthcare
Industry
Major Pharmaceutical Preparations
Latest News for LLY.TO
Risk & Correlation Analysis
Market Correlation
0.22
Low Correlation
Volatility
Medium (0.32)
Relative to market

Macro Factor Sensitivities

Interest Rates
Low Sensitivity
Inflation
Medium Sensitivity
GDP Growth
Low Sensitivity
Liquidity
Medium Sensitivity
Commodity Prices
Low Sensitivity
Credit Quality
Low Sensitivity
Portfolio Impact
Forecasts & Predictions

Premium Forecasts

Get AI-powered price predictions, technical analysis, and market forecasts for LLY.TO.

1-Month Target
$XXX.XX
+X.X% Potential
3-Month Target
$XXX.XX
+X.X% Potential
12-Month Target
$XXX.XX
+X.X% Potential

Technical Analysis

Based on technical indicators and chart patterns, LLY.TO shows...

AI Sentiment Analysis

Market sentiment analysis indicates...

Key Statistics
Market Cap$831.7B
Volume1.5M
P/E Ratio
Dividend Yield0.40%
Important Dates
Next Dividend
Next Earnings
August 7, 2025
Related Securities
MFC.TO
Manulife Financial Corporation
SLF.TO
Sun Life Financial Inc.
RY.TO
Royal Bank of Canada

PortfolioPilot Analysis

Get AI-powered insights on how LLY.TO fits into your investment strategy and portfolio diversification.

Pricing info last updated June 18, 2025 (after market close)Other info last updated April 2, 2025